Emergency tyvaso

Ended Purchase Order Awarded Last action

Contract number
36C26123P0590
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value 0% obligated
$85,327.92 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
San Francisco, CA 94121, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 -$85,328
Original award $85,328

About this award

This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Caremark RX, L.L.C., a subsidiary of CVS Health Corporation, for the emergency delivery of Tyvaso, a medication used to treat pulmonary arterial hypertension. The contract has a ceiling value of $85,327.92 and an ultimate completion date of January 30, 2023. The award does not contain a set-aside designation. Caremark RX has a history of providing specialty pharmaceuticals, including Tyvaso and other pulmonary hypertension medications, directly to VA medical facilities through similar short-term purchase orders. This contract supports the VA's mission to provide comprehensive healthcare services to eligible veterans.

Quick answers

Who was awarded contract 36C26123P0590?

36C26123P0590 was awarded to Caremark RX, L.L.C. by Veterans Integrated Service Network 21 (Veterans Health Administration) on January 26, 2023.

How much is contract 36C26123P0590 worth?

The government has obligated $0 on 36C26123P0590. Its current value, with exercised options, is $85,328.

Was contract 36C26123P0590 competed?

The extent of competition for 36C26123P0590 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award